Guy Gorochov

Author PubWeight™ 52.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009 9.01
2 Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004 3.50
3 The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006 2.35
4 Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005 2.00
5 Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood 2011 1.93
6 Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One 2013 1.86
7 Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets. Eur J Immunol 2011 1.59
8 Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 2011 1.59
9 Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev 2011 1.49
10 Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide. Proc Natl Acad Sci U S A 2008 1.43
11 Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study. Neuro Oncol 2010 1.30
12 HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood 2011 1.25
13 Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene 2003 1.23
14 Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS One 2012 1.11
15 An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. J Leukoc Biol 2009 1.10
16 Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog 2011 1.10
17 FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 2009 1.05
18 Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational study. PLoS One 2011 1.05
19 Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. J Virol 2003 1.00
20 Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev 2013 0.99
21 Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Arthritis Rheum 2003 0.96
22 Differential impact of age and cytomegalovirus infection on the γδ T cell compartment. J Immunol 2013 0.95
23 Cluster analysis of arterial involvement in Takayasu arteritis reveals symmetric extension of the lesions in paired arterial beds. Arthritis Rheum 2011 0.95
24 Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults. J Immunol 2012 0.95
25 The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. Autoimmun Rev 2012 0.92
26 Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Ann Rheum Dis 2012 0.92
27 Proteome-wide analysis and CXCL4 in systemic sclerosis. N Engl J Med 2014 0.91
28 Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes. AIDS Res Hum Retroviruses 2005 0.85
29 Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event. Mult Scler 2010 0.84
30 Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome. PLoS One 2008 0.83
31 Severe meningo-radiculo-neuritis associated with ipilimumab. Invest New Drugs 2012 0.82
32 Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine. Hum Gene Ther Methods 2014 0.81
33 Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccination. Vaccine 2008 0.78
34 Human lupus, fewer Treg cells indeed: comment on the article by Venigalla et al. Arthritis Rheum 2009 0.78
35 Phage-displayed libraries of peptide/major histocompatibility complexes. Eur J Immunol 2004 0.77
36 Correction: Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection. PLoS One 2015 0.76
37 Antagonistic T-cell subsets in skin diseases. N Engl J Med 2011 0.75
38 Properties of a disease-specific prion probe. Nat Med 2004 0.75
39 Host genetics affect microbial ecosystems via host immunity. Curr Opin Allergy Clin Immunol 2016 0.75
40 Remission of severe CD8(+) cytotoxic T cell skin infiltrative disease in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2010 0.75
41 High-sequence diversity and structural conservation in the human T-cell receptor β junctional region during thymic development. Eur J Immunol 2013 0.75